Frontage, an Exton contract research organization, has appointed Michael S. Willett president of its clinical business unit. Willett established Advanced Biomedical Research Inc., a Phase I-II clinical CRO acquired by Frontage in 2008. In 2009
Wharfedale (at Henley): M Wright; O Cicognini, C Hudson, H Morgan, D Tai; J Guy, H Skelton; J Altham, I Larkin, C Steel, J Mason, S Willett, G Hedgley, R Baldwin, J Burridge. Replacements: D Stockdale, M Beesley, A Howard, M Labasse, O Fewtrel